Ohr Pharmaceutical, Inc. 10-K/A
Exhibit 31.2
Certification of Chief Financial Officer
Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
I, Sam Backenroth, certify that:
1. | I have reviewed this report on Form 10-K of Ohr Pharmaceutical, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Dated: December 7, 2016
/s/ Sam Backenroth | |
Sam Backenroth |